These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6990666)

  • 1. Baseline pharmacology, electrophysiology and pharmacokinetics of mexiletine.
    Middleton D
    Acta Cardiol Suppl; 1980; (25):45-53. PubMed ID: 6990666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of mexiletine in renal insufficiency.
    Baudinet G; Henrard L; Quinaux N; El Allaf D; de Landsheere C; Carlier J; Dresse A
    Acta Cardiol Suppl; 1980; (25):55-65. PubMed ID: 6966453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrophysiologic actions of mexiletine (Kö-1173) in man].
    González Maqueda I; García Fernández F; Martín Jadraque L
    Med Clin (Barc); 1981 Mar; 76(5):223-5. PubMed ID: 7206892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology, electrophysiology, and pharmacokinetics of mexiletine.
    Woosley RL; Wang T; Stone W; Siddoway L; Thompson K; Duff HJ; Cerskus I; Roden D
    Am Heart J; 1984 May; 107(5 Pt 2):1058-65. PubMed ID: 6326558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological properties of mexiletine assessed with respect to plasma concentrations.
    Joseph SP; Holt DW
    Eur J Cardiol; 1980 Feb; 11(2):115-21. PubMed ID: 7363924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of the new antiarrhythmic drug mexiletine on sinus node and intracardiac conduction in man (author's transl)].
    Seipel L; Breithardt G; Schoerner U
    Z Kardiol; 1978 Nov; 67(11):766-70. PubMed ID: 726555
    [No Abstract]   [Full Text] [Related]  

  • 7. Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias.
    Chew CY; Collett J; Singh BN
    Drugs; 1979 Mar; 17(3):161-81. PubMed ID: 378646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and the antiarrhythmic effect of mexiletine in patients with chronic ventricular arrhythmias.
    Ohashi K; Ebihara A; Hashimoto T; Hosoda S; Kondo K; Oka T
    Arzneimittelforschung; 1984; 34(4):503-7. PubMed ID: 6540110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
    Carmeliet E
    Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of metoclopramide and atropine on the absorption of orally administered mexiletine.
    Wing LM; Meffin PJ; Grygiel JJ; Smith KJ; Birkett DJ
    Br J Clin Pharmacol; 1980 May; 9(5):505-9. PubMed ID: 6994791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrophysiological properties of mexiletine. Experimental study in the dog (author's transl)].
    Puech P; Roca J; Molina L; de Boisjelin X; Sassine A; Masse C
    Ann Cardiol Angeiol (Paris); 1979; 28(3):189-93. PubMed ID: 507724
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of intravenous mexiletine in patients with acute myocardial infarction.
    Pentikäinen PJ; Halinen MO; Helin MJ
    J Cardiovasc Pharmacol; 1984; 6(1):1-6. PubMed ID: 6199590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical antiarrhythmic efficacy of mexiletine: a review.
    Kulbertus HE
    Acta Cardiol Suppl; 1980; (25):111-20. PubMed ID: 6990663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology and clinical use of mexiletine.
    Fenster PE; Comess KA
    Pharmacotherapy; 1986; 6(1):1-9. PubMed ID: 3513138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: Clinical electrophysiological effects of mexiletine and its mechanism of antidysrhythmic action.
    McComish M; Crook B; Kitson D; Jewitt D
    Br Heart J; 1976 Mar; 38(3):311. PubMed ID: 1259850
    [No Abstract]   [Full Text] [Related]  

  • 16. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of mexiletine on steady-state characteristics and recovery kinetics of V max and conduction velocity in guinea pig myocardium.
    Hohnloser S; Weirich J; Antoni H
    J Cardiovasc Pharmacol; 1982; 4(2):232-9. PubMed ID: 6175806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemodynamic and electrophysiological effects of intravenous injection of mexiletine].
    Tanaka T; Kusumoto M; Umemura J; Miyazawa Y; Suwa J; Komatsu Y
    Kokyu To Junkan; 1983 Dec; 31(12):1355-60. PubMed ID: 6676806
    [No Abstract]   [Full Text] [Related]  

  • 19. Preferential action of mexiletine on central common pathway of reentrant ventricular tachycardia.
    Aizawa Y; Abe A; Ohira K; Furushima H; Chinushi M; Fujita S
    J Am Coll Cardiol; 1996 Dec; 28(7):1759-64. PubMed ID: 8962563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological mechanisms for the antiarrhythmic action of mexiletine on digitalis-, reperfusion- and reoxygenation-induced arrhythmias.
    Amerini S; Carbonin P; Cerbai E; Giotti A; Mugelli A; Pahor M
    Br J Pharmacol; 1985 Dec; 86(4):805-15. PubMed ID: 4075017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.